Panzyga 100 mg/ml solution for infusion
Human normal immunoglobulin (IVIg)
Replacement therapy in adults, and children and adolescents (0-18 years) in:
Replacement therapy in adults, and children and adolescents (0-18 years) in:
- Primary immunodeficiency (PID) syndromes with impaired antibody production (see section 4.4).
- Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
- Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.
- Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
- Congenital AIDS with recurrent bacterial infections.
- Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.
- Guillain Barré syndrome.
- Kawasaki disease.
Available pack sizes:
10 ml, N1
25 ml, N1
50 ml, N1
60 ml, N1
100 ml, N1
100 ml, N3
200 ml, N1
200 ml, N3
300 ml, N1
10 ml, N1
25 ml, N1
50 ml, N1
60 ml, N1
100 ml, N1
100 ml, N3
200 ml, N1
200 ml, N3
300 ml, N1
